By targeting lipid metabolism, oxidative stress, inflammation, and insulin sensitivity, along with dietary interventions, these therapeutic mechanisms provide a comprehensive strategy for managing and potentially reversing the progression of MASH and MASLD. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.